On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

UCB Pharma (United Kingdom)

InstitutionResearch output, impact & collaborations

UCB Pharma (United Kingdom) is a institution indexed in ScholarIQ from OpenAlex.

What is known about UCB Pharma (United Kingdom)?

ScholarIQrecord summary

UCB Pharma (United Kingdom) is a research organisation in Slough, GB. OpenAlex records 2,205 works and 234,306 citations for it. 562 researchers list it as their most recent affiliation.

How many works does UCB Pharma (United Kingdom) have?

ScholarIQindexed works

UCB Pharma (United Kingdom) has 2,205 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for UCB Pharma (United Kingdom) →

How many citations does UCB Pharma (United Kingdom) have?

ScholarIQcitation count

UCB Pharma (United Kingdom) has 234,306 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for UCB Pharma (United Kingdom) →

How many researchers are at UCB Pharma (United Kingdom)?

ScholarIQresearcher count

UCB Pharma (United Kingdom) has 562 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at UCB Pharma (United Kingdom)?

ScholarIQavg h-index

UCB Pharma (United Kingdom) has an average h-index of 45 in OpenAlex.

Open the OpenAlex record →

What is the ROR of UCB Pharma (United Kingdom)?

ScholarIQror

The ROR for UCB Pharma (United Kingdom) is on the source record.

Open the ROR →

What is the OpenAlex record for UCB Pharma (United Kingdom)?

ScholarIQopenalex

The OpenAlex for UCB Pharma (United Kingdom) is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind UCB Pharma (United Kingdom)?

ScholarIQtop researchers by citations

Ioana Cutcutache · Genetic factors in colorectal cancer

180 works35,880 citations

What are the most-cited papers on UCB Pharma (United Kingdom)?

ScholarIQmost cited works

Early childhood epilepsies: epidemiology, classification, aetiology, and socio-economic determinants

Joseph D. Symonds, Katherine S. Elliott, Jay Shetty, Martin Armstrong, Andreas Brunklaus, Ioana Cutcutache, Louise A Diver, Liam Dorris, Sarah L. Gardiner, Alice Jollands, Shelagh Joss, Martin Kirkpatrick, Ailsa McLellan, Stewart Macleod, Mary O’Regan, Matthew Page, Elizabeth Pilley, Daniela T. Pilz, Elma Stephen, Kirsty Stewart, Houman Ashrafian, Julian C. Knight, Sameer M. Zuberi

Brain. 2021251 CitationsOPEN ACCESS

Early-onset autoimmunity associated with SOCS1 haploinsufficiency

Jérôme Hadjadj, Carla N. Castro, Maud Tusseau, Marie‐Claude Stolzenberg, Fabienne Mazerolles, Nathalie Aladjidi, Martin Armstrong, Houman Ashrafian, Ioana Cutcutache, Georg Ebetsberger‐Dachs, Katherine S. Elliott, I. Durieu, Nicole Fabien, Mathieu Fusaro, Maximilian Heeg, Yohan Schmitt, Marc Bras, Julian C. Knight, Jean‐Christophe Lega, Gaëtan Lesca, Anne‐Laure Mathieu, Marion Moreews, Baptiste Moreira, Audrey Nosbaum, Matthew J. Page, Cécile Picard, Timothy Ronan Leahy, Isabelle Rouvet, Ethel Ryan, Damien Sanlaville, Klaus Schwarz, Andrew Skelton, Jean‐François Viallard, Sébastien Viel, Marine Villard, Isabelle Callebaut, Capucine Pïcard, Thierry Walzer, Stephan Ehl, Alain Fischer, Bénédicte Neven, Alexandre Bélot, Frédéric Rieux‐Laucat

Nature Communications. 2020153 CitationsOPEN ACCESS

How much of the research on UCB Pharma (United Kingdom) is open access?

ScholarIQopen access share

100%OPEN ACCESS

Gold

50%

Green

Hybrid

50%

Bronze

Closed